# Low positive and borderline negative transglutaminase antibody levels are frequently associated with a coeliac disease diagnosis

**Authors:** Rakel Nurmi, Celina Turunen Beteta, Kalle Kurppa, Heini Huhtala, Katri Lindfors, Laura Kivelä, Katri Kaukinen, Saana Paavola

PMC · DOI: 10.1111/joim.70025 · 2025-09-25

## TL;DR

Low and borderline transglutaminase antibody levels often indicate coeliac disease, especially when combined with other markers like EmA.

## Contribution

The study clarifies the clinical significance of low and borderline TGA levels in diagnosing coeliac disease.

## Key findings

- Low positive TGA values are frequently associated with coeliac disease diagnosis.
- Borderline negative TGA values may indicate early-stage coeliac disease.
- EmA positivity strongly correlates with coeliac disease in these TGA ranges.

## Abstract

Due to the expanding screening of coeliac disease (CeD), low positive and borderline negative serum transglutaminase 2 antibody (TGA) values are causing increasing confusion in clinical practice.

To investigate the significance of these findings in a well‐defined patient cohort.

Altogether 311 IgA‐competent adults, with clinical suspicion or family history of CeD, underwent duodenal sampling and testing for TGA (ImmunoCAP EliA, cut‐off 7.0 U/mL) and endomysial antibodies (EmA). TGA values 7.0–14.0 U/mL were defined as low positive and 3.0–6.9 U/mL as borderline negative. Besides conventional histology, small bowel mucosal TGA‐targeted IgA deposits and γδ+ intraepithelial lymphocytes (IELs) were determined as CeD‐specific markers.

Twenty‐eight (9%) individuals had low positive TGA, and 22 (79%) were also positive for EmA. Among those with low positive TGA, all EmA positive and 50% of the EmA negative subjects were diagnosed with CeD. Thirty‐nine individuals (13%) had borderline negative TGA, and 36% were positive for EmA. Of these, 79% of EmA positive and 12% of EmA negative subjects were diagnosed with CeD. Additionally, 29% of the subjects with borderline negative TGA and no diagnosis exhibited signs of incipient CeD, including positive IgA deposits, increased density of γδ+ IELs and presence of human leukocyte antigen DQ2/DQ8. All subjects with TGA ≥ 3.2× upper limit of normal (22.4 U/mL) received a CeD diagnosis.

Low positive and borderline negative TGA frequently implies a CeD diagnosis, particularly in EmA positive individuals, or at least may be an indicator of an early stage of the disease.

## Linked entities

- **Proteins:** CD79A (CD79a molecule)

## Full-text entities

- **Genes:** TGM2 (transglutaminase 2) [NCBI Gene 7052] {aka G(h), TG(C), TGC, hTG2, tTG}, CD79A (CD79a molecule) [NCBI Gene 973] {aka IGA, IGAlpha, MB-1, MB1}
- **Diseases:** CeD (MESH:D004194)
- **Chemicals:** EmA. (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12617477/full.md

---
Source: https://tomesphere.com/paper/PMC12617477